GIS:FRA
गिलियड साइन्सेस
€ १५२.६६
arrow_downward
-०.३५%(-०.५४) 1D
नोभेम्बर १३, २२:००:०० GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€ १५१.१४
High
€ १५२.६६
Low
€ १५१.१४
Mkt. cap
२.०८ खरब
Avg. vol.
२२४.००
Volume
५६.००
52-wk high
€ १५७.१४
52-wk low
€ १००.४२
No. of employees
१७ हजार
Open
€ १५१.१४
High
€ १५२.६६
Low
€ १५१.१४
Mkt. cap
२.०८ खरब
Avg. vol.
२२४.००
Volume
५६.००
52-wk high
€ १५७.१४
52-wk low
€ १००.४२
No. of employees
१७ हजार
News stories
From web sources and news partners
Yahoo Finance
·
२ दिन पहिले
The Zacks Analyst Blog Highlights Home Depot, Gilead Sciences, TotalEnergies, Key Tronic and iPower
The Globe and Mail
·
२ दिन पहिले
Can Gilead Sciences' HIV Business Fuel Sustainable Long-Term Growth?
Investing.com
·
२ दिन पहिले
Argus raises Gilead Sciences stock price target on pipeline strength
Yahoo Finance
·
२ दिन पहिले
Gilead Sciences, Inc. (GILD) Stock Forecasts
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About गिलियड साइन्सेस
CEODaniel O'Day
Employees१७ हजार
Founded१९८७ जुन २२
HeadquartersFoster City, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitegilead.com